Two “Must Own” Vaccine Stocks with More Upside Ahead

The pandemic is a “humanitarian disaster,” as noted by CNN.

And there’s no slowdown in sight.

At the moment, the world is up to 52.2 million cases, with 1.286 million unfortunate deaths. In the U.S., we have 10.4 million cases. In India, 8.6 million. In Brazil, 5.7 million. France is nearing two million. Russia is up to 1.84 million.

Fortunately, we may be nearing a vaccine.

Pfizer for example, announced its COVID-19 vaccine is 90% effective. 

“Amazing news from Pfizer with 90% efficacy. This hopefully is the beginning of the end of our fight against Covid,” Peter Boockvar, chief investment officer at Bleakley Advisory Group, said, as quoted by CNBC.

Shares of Moderna are exploding on news Dr. Fauci said its upcoming vaccine trial data may be positive. “Moderna has seen a significant increase in the rate of case identification across sites in the last week,” the company said. 

“As a result, the company expects the first interim analysis will include substantially more than 53 cases, the targeted trigger point for the analysis.”